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Background: The aetiology of perioperative myocardial injury is poorly understood and not clearly linked to pre-existing
cardiovascular disease. We hypothesised that loss of cardioprotective vagal tone [defined by impaired heart rate recovery
12 beats min1 (HRR 12) 1 min after cessation of preoperative cardiopulmonary exercise testing] was associated with
perioperative myocardial injury.
Methods: We conducted a pre-defined, secondary analysis of a multi-centre prospective cohort study of preoperative
cardiopulmonary exercise testing. Participants were aged 40 yr undergoing non-cardiac surgery. The exposure was
impaired HRR (HRR12). The primary outcome was postoperative myocardial injury, defined by serum troponin con-
centration within 72 h after surgery. The analysis accounted for established markers of cardiac risk [Revised Cardiac Risk
Index (RCRI), N-terminal pro-brain natriuretic peptide (NT pro-BNP)].
Results: A total of 1326 participants were included [mean age (standard deviation), 64 (10) yr], of whom 816 (61.5%) were
male. HRR12 occurred in 548 patients (41.3%). Myocardial injury was more frequent amongst patients with HRR12 [85/
548 (15.5%) vs HRR>12: 83/778 (10.7%); odds ratio (OR), 1.50 (1.08e2.08); P¼0.016, adjusted for RCRI). HRR declined pro-
gressively in patients with increasing numbers of RCRI factors. Patients with 3 RCRI factors were more likely to have
HRR12 [26/36 (72.2%) vs 0 factors: 167/419 (39.9%); OR, 3.92 (1.84e8.34); P<0.001]. NT pro-BNP greater than a standard
prognostic threshold (>300 pg ml1) was more frequent in patients with HRR12 [96/529 (18.1%) vs HRR>12 59/745 (7.9%);
OR, 2.58 (1.82e3.64); P<0.001].
Conclusions: Impaired HRR is associated with an increased risk of perioperative cardiac injury. These data suggest a
mechanistic role for cardiac vagal dysfunction in promoting perioperative myocardial injury.Editorial decision: 20 October 2018; Accepted: 20 October 2018
© 2018 The Author(s). Published by Elsevier Ltd on behalf of British Journal of Anaesthesia. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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 The hypothesis of this study was that cardiac vagal
dysfunction, manifesting as impaired heart rate
deceleration after exercise (defined as heart rate re-
covery 12 beats min1), is associated with periopera-
tive myocardial injury.
 To test this, investigators conducted a planned sub-
group analysis of patients enrolled in an interna-
tional, prospective, multi-centre cohort study.
 Patients with an increased preoperative Lee’s Revised
Cardiac Risk Index, and those with an elevation of N-
terminal pro B-type natriuretic peptide (a counter-
regulatory hormone released by the ventricle in the
setting of cardiac dysfunction), had impaired heart rate
deceleration after cardiopulmonary exercise testing.
 As hypothesised, impaired heart rate deceleration after
exercise was independently associated with myocar-
dial injury, based on troponin elevation, after non-
cardiac surgery.
 Cardiac vagal dysfunction could increase perioperative
myocardial oxygen requirements, and thusmight be an
important mechanistic contributor to perioperative
myocardial injury.The majority of the estimated 300 million surgical patients
each year undergo non-cardiac procedures.1 Around 20% of
non-cardiac surgical patients sustain perioperative myocar-
dial injury,2,3 which is usually asymptomatic yet strongly
associated with hospital readmission4 and mortality.5e9
Myocardial injury is more common in patients with estab-
lished cardiovascular risk factors, as estimated using the
Revised Cardiac Risk Index (RCRI).6,10e12 However, conven-
tional treatments for myocardial infarction do not reduce
myocardial injury, cardiovascular death, or both after non-
cardiac surgery.13e15 Moreover, objective measures of athero-
sclerosis using computed tomography coronary angiogram
correlate poorly with the risk of perioperative myocardial
injury and do not increase the predictive utility of the RCRI.16
Resting heart rate is independently associated with car-
diovascular morbidity and mortality, both in the general
population17,18 and in patients undergoing non-cardiac sur-
gery.6,19 Cardiac vagal activity is the major autonomic deter-
minant of resting heart rate.20,21 In pathologic settings, the
loss of cardiac vagal activity exacerbates myocardial cellular
injury after acute inflammation, haemorrhage, and
ischaemia.22e25 Parasympathetic dysfunction, as reflected by
delayed heart rate recovery (HRR) after graded exercise, is
common among people with cardiometabolic risk factors that
comprise the RCRI.16,26 Parasympathetic dysfunction could
therefore promote myocardial injury, exacerbate myocardial
injury, or both through several relevant pathophysiological
mechanisms characterised by acute inflammation, tissue ox-
ygen supplyedemand imbalance, arterial hypotension, orboth. Loss of cardioprotective mechanisms to counteract such
cardiovascular challenges may result in myocardial injury.
Taken together, it is plausible that established cardiac vagal
dysfunction may be an unrecognised factor in promoting
perioperative myocardial injury.
The Measurement of Exercise Tolerance before Surgery
(METS) study found no relationship between objective
markers of exercise capacity measured using cardiopulmo-
nary exercise testing (CPET; peak oxygen consumption and
anaerobic threshold) and perioperative myocardial injury.27 In
the same large prospective multi-centre cohort study, we
prospectively tested the hypothesis that cardiac vagal
dysfunction, as defined by impaired HRR, was associated with
increased risk of myocardial injury after non-cardiac surgery.
HRR, which was measured after preoperative CPET,28 is an
established measure of cardiac vagal tone that is associated
with all-cause mortality, independent of other exercise test
parameters.29,30 We further tested this hypothesis by
exploring whether impaired HRR was associated with estab-
lished preoperative risk factors for postoperative cardiovas-
cular complications, on the basis that loss of cardioprotective
vagal activity (as reflected by lower HRR) provides a plausible
unifying mechanism linking clinical and biochemical predic-
tive indicators with perioperative myocardial injury.Methods
Study design and setting
This was a pre-defined secondary analysis of the METS study,
an international prospective observational cohort study of
preoperative assessment before non-cardiac surgery at 25
hospitals in Canada, UK, Australia, and New Zealand.27 The
study protocol and methods were published previously.31 The
study received research ethics approval before participant
recruitment started and was conducted in accordance with
the principles of the Declaration of Helsinki and the Research
Governance Framework.Participants
Participants were 40 yr of age or older, undergoing elective
non-cardiac surgery under general anaesthesia, regional
anaesthesia, or both with a planned overnight stay in hospital,
and with at least one of the following perioperative risk fac-
tors: intermediate or high-risk surgery, coronary artery dis-
ease, heart failure, cerebrovascular disease, diabetes mellitus,
preoperative renal insufficiency, peripheral arterial disease,
hypertension, a history of tobacco smoking within the previ-
ous year, or aged 70 yr or older. The exclusion criteria were:
planned procedure using only endovascular technique, use of
CPET for risk stratification as part of routine care, insufficient
time for CPET before surgery, presence of an implantable
cardioverteredefibrillator, known or suspected pregnancy,
previous enrolment in the study, severe hypertension (>180/
190 - Abbott et al.100 mm Hg), active cardiac conditions, or other contraindica-
tions precluding CPET.31,32 Participants gave written informed
consent to take part before surgery.Study conduct and data collection
A detailed and standardised dataset was collected before
surgery, during the hospital stay, and at 30 days and 1 yr after
surgery. Researchers collected data directly from participants
and their medical record. Each participant underwent preop-
erative CPET. Blood was sampled before surgery and on the
first, second, and third days after surgery, as long as the
participant remained in hospital. In Canada, Australia, and
New Zealand, serum cardiac troponin (either I or T isoforms)
concentration was measured in preoperative and post-
operative samples at local hospital laboratories, according to
local policy. In the UK, serum cardiac troponin was measured
in preoperative and postoperative samples at a single central
laboratory. A summary of the troponin assays used at each
centre is summarised in Supplementary Table S1. N-terminal
pro-hormone of brain natriuretic peptide (NT pro-BNP) con-
centration, which has been shown to predict perioperative
cardiac events, was measured in all preoperative samples at a
single central laboratory.33 Electrocardiograms were per-
formed before surgery and on the first, second, and third days
after surgery.Cardiopulmonary exercise testing
Participants underwent preoperative symptom-limited CPET
using a standardised incremental ramp protocol using elec-
tromagnetically braked cycle ergometers, as described and
published previously.27,31 HRR during the first minute of the
recovery periodwas calculated as the difference between heart
rate at the endof the incremental exercise andheart rate after 1
min of the recovery period. Clinicians, patients, and outcome
adjudicators were blinded to the results of CPET, except where
there was a safety concern according to pre-defined criteria.31Exposures and outcomes
The exposure of interest was impaired HRR, defined as
reduction in heart rate of 12 beats min1 during the first
minute after the end of preoperative CPET. This threshold is
prognostically associated with subsequent cardiovascular
morbidity in the general29 and surgical populations.34 The
primary outcome measure was myocardial injury, defined as
blood troponin T or I concentration greater than the limit of
the reference range (99th centile) for each assay, within 72 h
after surgery. Troponin assays differed between participating
hospitals and are listed in Supplementary Table S1. Pre-
defined explanatory variables that may confound an associa-
tion between impaired HRR and myocardial injury are
commonly used preoperative cardiovascular risk indicators,
namely, NT pro-BNP concentration and RCRI, which are both
prognostically associated with postoperative myocardial
infarction.33,35 We used a threshold of >300 pg ml1 for pre-
operative NT pro-BNP concentration which appears to predict
postoperative cardiovascular events in surgical patients.33Statistical analysis
We used STATA version 14 (STATACorp LP, College Station,
TX, USA) to analyse the data. The small number ofparticipants without a record of HRR were excluded. We
ranked the sample by HRR at 1 min after the end of incre-
mental exercise and dichotomised it according to a
threshold of 12 beats min1. We presented baseline char-
acteristics for the whole cohort and stratified by HRR. Nor-
mally distributed data were expressed as mean (standard
deviation, SD), and non-normally distributed data were
expressed as median (inter-quartile range, IQR). Binary data
were expressed as percentages. We performed a complete
case analysis. First, we used univariable logistic regression
analysis to measure the unadjusted association between
impaired HRR and myocardial injury. Second, using a pre-
viously published method for stratifying patients at risk of
perioperative myocardial injury, we divided the cohort into
three groups according to RCRI [low-risk (RCRI 0 points),
intermediate-risk (RCRI 1e2 points), or higher risk35 (RCRI
3e6 points)], which represents multiple cardiovascular risk
factors known to be associated with perioperative myocar-
dial injury.6,8,10,11,35e37 We constructed a multivariable lo-
gistic regression model to determine the association
between impaired HRR and myocardial injury, after adjust-
ment for RCRI, where the low-risk group was considered the
reference category. Third, we repeated the multivariable
logistic regression model, adjusted for component cardio-
vascular risk factors of the RCRI, including: coronary artery
disease, heart failure, diabetes mellitus requiring insulin
therapy, and preoperative renal insufficiency (creatinine
>177 mmol L1).11,35 The results of logistic regression ana-
lyses were presented as odds ratios (OR) with 95% confi-
dence intervals. The threshold for statistical significance
was P0.05.Secondary analysis
We characterised the mean HRR and the proportion of par-
ticipants with impaired HRR within strata defined by RCRI.
Additionally, we used univariable logistic regression to char-
acterise the unadjusted association between RCRI-defined risk
groups and impaired HRR, where the lowest-risk group was
considered the reference category. We also characterised the
mean HRR and the proportion of participants with impaired
HRR within strata defined by NT Pro-BNP (>300 or 300 pg
ml1).33 To explore a potential trend in relationship between
HRR and NT Pro-BNP, we plotted bar charts showing both the
proportion (%) of participants with HRR12 beats min1, and
mean HRR (beats min1), stratified by NT pro-BNP concentra-
tion (<100, 100e199 and 200 pg ml1).Sensitivity analysis
To take account of potential confounding by heart rate-
limiting medications, we repeated the primary analysis
including negatively chronotropic cardiovascular medications
(beta-blockers and non-dihydropyridine calcium channel an-
tagonists) as covariates.Sample size calculation
This was a planned secondary analysis of a prospectively
collected data. The sample size was determined based on the
comparisons being made in the principal analysis, which has
been published previously.27 For this sub-study, we included
all available cases such that the sample size was based on
convenience.
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Study sample
A total of 1741 patients were recruited into the METS study
between March 2013 and March 2016. After pre-defined
exclusion of patients who did not undergo preoperative CPET
(n¼147) or surgery (n¼54), or had incomplete CPET data
including absent measurement of HRR (n¼53), we analysed
data obtained from 1326 participants (Fig. 1). Their mean age
was 64 (10) yr; 816 (61.5%) were male and 750 (56.6%) under-
went high-risk surgery. Overall, 1207 (91%) patients were
classified as ASA Physical Status (ASA-PS) class 2 or 3, and 1144
(86%) underwent major abdominal, pelvic, or orthopaedic
procedures. The baseline characteristics of the cohort are
summarised in Table 1.Assessment of heart rate recovery
The mean HRR at 1 min after the end of preoperative incre-
mental workload cardiopulmonary exercise test (HRR) was 15
(12) beats min1. The distribution of HRR is shown in Fig. 2.
Preoperative HRR 12 beats min1 was present in 548/1326Fig 1. Patient flow diagram showing the number of patients included i(41.3%) patients. Mean resting heart rate was 77 (14) beats
min1. Resting heart rate, VO2 peak, and anaerobic threshold
stratified by HRR12 beatsmin1 are shown in Table 1. Factors
included in the RCRI stratified by HRR 12 beats min1 are
shown in Table 2.Primary outcome
Postoperative myocardial injury was sustained by 168/1326
(12.7%) patients and was more frequent in patients with
impaired HRR [HRR12: 85/548 (15.5%) patients vs HRR>12: 83/
778 (10.7%) patients; OR, 1.54 (1.11e2.13); P¼0.009]. When the
analysis was adjusted for baseline cardiovascular risk defined
by RCRI score (Supplementary Table S2) and individual
component risk factors of the RCRI (Supplementary Table S3),
impaired HRR remained associated with myocardial injury.Sensitivity analysis
When we corrected the primary analysis for heart rate-
limiting medication and VO2 peak, the results were similar
(Supplementary Table S4).n the analysis. CPET, cardiopulmonary exercise testing.
Table 1 Baseline patient characteristics. Descriptive data stratified by preoperative heart rate recovery (HRR) 12 beats min1 in the
first minute after the end of cardiopulmonary exercise testing. Data are presented as frequencies with percentages (%) or means with
standard deviations (SD). Continuous data are reported to one decimal place and categorical data are rounded to the nearest whole
number. ASA, American Society of Anesthesiologists
Whole cohort HRR≤12 HRR>12
Number of patients, n 1326 548 778
Age, mean (SD) 64.2 (10.3) 66.7 (10.0) 62.5 (10.2)
Male sex (%) 816 (61.5) 315 (57.5) 501 (64.4)
Pre-existing conditions (%)
Atrial fibrillation 50 (3.8) 23 (4.2) 27 (3.5)
Diabetes mellitus 247 (18.6) 125 (22.8) 122 (15.7)
Hypertension 725 (54.7) 336 (61.3) 389 (50.0)
Peripheral artery disease 37 (2.8) 17 (3.1) 20 (2.6)
Chronic obstructive pulmonary disease 155 (11.7) 81 (14.8) 74 (9.5)
Surgical procedure type (%)
Vascular 25 (1.9) 14 (2.6) 11 (1.4)
Intraperitoneal or retroperitoneal 434 (32.7) 178 (32.5) 256 (32.9)
Urological or gynaecological 398 (30.0) 161 (29.4) 237 (30.5)
Intra-thoracic 30 (2.3) 11 (2.0) 19 (2.4)
Orthopaedic 312 (23.5) 131 (23.9) 181 (23.3)
Head and neck 82 (6.2) 34 (6.2) 48 (6.2)
Other 45 (3.4) 19 (3.5) 26 (3.3)
ASA-physical status (%)
1 99 (7.5) 33 (6.0) 66 (8.5)
2 780 (58.9) 303 (55.4) 477 (61.4)
3 427 (32.3) 203 (37.1) 224 (28.8)
4 18 (1.4) 8 (1.5) 10 (1.3)
Preoperative medication (%)
Beta-blockers 215 (16.2) 120 (21.9) 95 (12.2)
Diltiazem or verapamil 26 (2.0) 14 (2.6) 12 (1.5)
Preoperative cardiopulmonary exercise test variables
Resting heart rate (beats min1) 77 (14.1) 81 (15.2) 75 (12.7)
Peak oxygen consumption (ml kg min1) 19.3 (6.4) 17.1 (5.6) 20.8 (6.5)
Anaerobic threshold (ml kg min1) 12.7 (4.1) 11.6 (3.4) 13.4 (4.4)
Fig 2. Heart rate recovery 1 min after the end of exercise. Histogram showing the frequency distribution of heart rate recovery 1 min after
the end of exercise in beats min1.
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Table 2 Revised Cardiac Risk Index (RCRI) and NT pro-BNP Risk factors included in the RCRI and RCRI score,11 stratified by preoperative
heart rate recovery (HRR) 12 beats min1 in the first minute after the end of cardiopulmonary exercise testing. Data are presented as
frequencies with percentages (%) or median with inter-quartile range. Continuous data are reported to one decimal place and cate-
gorical data are rounded to the nearest whole number. NT Pro-BNP, N-terminal pro-hormone of brain natriuretic peptide
Whole cohort HRR≤12 HRR>12
Components of the RCRI (%)
High-risk surgery 750 (56.6) 311 (56.8) 439 (56.4)
Heart failure 17 (1.3) 11 (2.0) 6 (0.8)
Coronary artery disease 153 (11.5) 84 (15.3) 69 (8.9)
Cerebrovascular disease 54 (4.1) 28 (5.1) 26 (3.3)
Preoperative creatinine >177 mmol L1 100 (7.5) 43 (7.9) 57 (7.3)
Insulin therapy 54 (4.1) 26 (4.7) 28 (3.6)
RCRI score (%)
0 419 (31.6) 167 (30.5) 252 (32.4)
1e2 871 (65.7) 355 (64.8) 516 (66.3)
3 36 (2.7) 26 (4.7) 10 (1.3)
NT pro-BNP (pg ml1) 82 (40e166) 100 (47e222) 76 (35e137)
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The RCRI is prognostically associated with cardiovascular
complications after non-cardiac surgery.11 We found that the
proportion of participants with HRR12 beatsmin1 increased
with higher RCRI score (Fig. 3a). Similarly, mean HRR pro-
gressively declined in patients with increasing frequency of
RCRI-defined risk factors (Fig. 3b and Supplementary Table S5).
Participants with three or more RCRI-defined cardiovascular
risk factors were more likely to have impaired HRR compared
with those with none [RCRI3: 26/36 (72.2%) vs RCRI¼0: 167/
419 (39.9%); OR, 3.92 (1.84e8.34); P<0.001].Preoperative NT pro-BNP concentration
Elevated preoperative NT pro-BNP (>300 pg ml1) is a known
risk factor for postoperative cardiovascular complications.33,35
Elevated preoperative NT pro-BNP (>300 pg ml1) concentra-
tion was present in 155/1325 (12.2%) patients, of whom only
11/155 (7.1%) had a pre-existing clinical diagnosis of heart
failure. Of 155 patients with elevated NT pro-BNP concentra-
tion, 96 (61.9%) had HRR 12 beats min1 compared with 433/
1119 (38.7%) with NT pro-BNP 300 pg ml1 [OR, 2.58
(1.82e3.64); P<0.001]. The proportion of participants with HRR
12 beats min1 increased with increasing concentrations of
preoperative NT pro-BNP (Fig. 4a). Absolute HRR values
declined in patients with increasing concentrations of preop-
erative NT pro-BNP (Fig. 4b).Discussion
The principal finding of this planned analysis of the METS
study was that lower HRR after exercise, which reflects cardiac
vagal dysfunction, was independently associated with
myocardial injury after non-cardiac surgery after adjusting for
preoperative cardiovascular risk factors (RCRI). Our study
identifies an association between cardiac vagal dysfunction
and objective biochemical evidence of myocardial injury after
non-cardiac surgery. We used a HRR threshold that is prog-
nostically associated with cardiovascular morbidity and mor-
tality in large general population-based longitudinal cohorts.
These present results are also consistent with our recent
findings from another surgical cohort where impaired HRRbefore surgery was also associated with poorer postoperative
clinical outcomes.34,38
In keeping with a relationship between impaired HRR and
perioperative myocardial injury, we also found that patients
with three or more cardiovascular risk factors, as defined by
the RCRI, had impaired HRR. This suggests that pathophysio-
logical mechanisms other than atherosclerosis, but commonly
found amongst clinical phenotypes described by the RCRI,
may contribute to perioperative myocardial injury. Notably,
higher RCRI scores are associated with perioperative myocar-
dial injury irrespective of the contributing factors.12
We propose that preoperative risk factors, as defined by the
RCRI, are pathophysiologically linked to myocardial injury, in
part, through the common underlying mechanism of cardiac
vagal dysfunction. Parasympathetic dysfunction is common
among people with cardiometabolic risk factors that comprise
the RCRI.26 The association between HRR and RCRI may
explain why multiple factors have been repeatedly associated
with perioperative myocardial injury, even though the cu-
mulative risk is not dependent on a specific combination of
risk factors incorporated into the RCRI.6,8,10,37,39 Consistent
with these findings, we also show that elevated concentra-
tions of plasma NT pro-BNP, which is predictive of myocardial
injurymortality in non-cardiac surgery, is also associated with
impaired HRR.33
Our data are consistent with substantial evidence sup-
porting the hypothesis that loss of cardioprotective para-
sympathetic autonomic function promotes myocardial injury
after non-cardiac surgery. Cardiac vagal dysfunction, as
identified by low baroreflex sensitivity, reduced heart recovery
after exercise or impaired heart rate variability, is common in
surgical patients.34,38,40 Moreover, poor preoperative exercise
performance, which is regulated by efferent vagal nerve ac-
tivity,41 is associated with increased morbidity after major
surgery.27 Cardiac vagal tone protects the heart through
several physiological mechanisms, including inhibition of the
renineangiotensin aldosterone system and nitric oxide
expression.42 Vagal activity may also confer an anti-
inflammatory effect, which limits myocardial injury in
several experimental paradigms.22,25,43 Laboratory data
demonstrate that efferent vagal nerve activity reduces
inflammation, via release of acetylcholine and vasoactive in-
testinal peptide.44 In humans, reduced HRR is associated with
Fig 3. Heart rate recovery and Revised Cardiac Risk Index (RCRI). Bar charts showing (a) the proportion (%) of participants with heart rate
recovery (HRR) less than or equal to 12 beats min1, and (b) mean heart rate recovery (beats min1), stratified by the RCRI. Error bars
indicate the 95% confidence interval for the mean. Overall, 167/419 patients with RCRI¼0 had heart rate recovery 12 beats min1, 355/871
patients with RCRI¼1e2 had heart rate recovery 12 beats min1, and 26/36 patients with RCRI 3 had heart rate recovery 12 beats min1.
The proportion of patients with heart rate recovery 12 beats min1 was significantly greater for RCRI 3 compared with the other two
groups (P<0.01).
194 - Abbott et al.elevated neutrophil/lymphocyte ratio,45 a robust marker for
chronic systemic inflammation that is associated with peri-
operative cardiovascular morbidity and mortality.40 Reduced
cardiac vagal activity predisposes to cardiac arrhythmias,46
particularly atrial fibrillation, which are also associated with
plasma troponin elevation.Study strengths and limitations
A strength of this study was its prospective, international,
multi-centre design, which make the results generalisable to
the majority of patients undergoing non-cardiac surgery.
Secondly, the primary outcome, myocardial injury, is an
objective biochemical indicator and encompasses the full
spectrum of myocardial injury after non-cardiac surgery.47
Although HRR declines with chronological age,26 it is notable,
yet frequently overlooked, that older age is consistently linkedto perioperative myocardial injury.6,10,37 The potential for
measurement error, observer bias, or both between multiple
METS study sites was mitigated by the prospective use of a
standardised exercise testing protocol and interpretation
guidelines, and a standard case report form for collecting ex-
ercise test data.31 Limitations of this study include its obser-
vational design, precluding any conclusions regarding
causality. These findings do not prove that impaired vagal
activity is the causal mechanism behind myocardial injury; it
could be a surrogate marker of the underlying mechanism.
Although the use of a cut-off value of ~12 beatsmin1 has been
demonstrated to have prognostic value in general medical
populations, our ongoing work in an even larger population
will refine the optimal parameter relevant for the periopera-
tive setting.48e50 The addition of intraoperative haemody-
namic data would add further insight into the relationship
between cardiac vagal autonomic dysfunction, impaired
Fig 4. Heart rate recovery and NT Pro-BNP. Bar charts showing (a) the proportion (%) of participants with heart rate recovery 12 beats
min1, and (b) mean heart rate recovery (beats min1), stratified by NT pro-BNP concentration (<100, 100e199, and 200 pg ml1). Error bars
indicate the 95% confidence interval for the mean. Overall, 263/719 (36.6%) patients with NT pro-BNP <100 pg ml1 had heart rate recovery
12 beats min1, 119/291 (40.9%) patients with NT pro-BNP 100e199 pg ml1 had heart rate recovery 12 beats min1, and 146/263 (55.5%)
patients with NT pro-BNP 200 pg ml1 had heart rate recovery 12 beats min1. NT Pro-BNP, N-terminal pro-hormone of brain natriuretic
peptide.
Cardiac vagal dysfunction and myocardial injury - 195aerobic capacity, and hypotension, which is associated with
perioperative myocardial injury.51 Although previous studies
have established that impaired HRR is strongly associated
with other measures of cardiac vagal autonomic dysfunc-
tion,34,52 the lack of other autonomic measures in this study
may limit generalisability beyond CPET-derived parameters.Conclusions
Cardiac vagal (parasympathetic) dysfunction, characterised by
impaired heart rate recovery after preoperative exercise
testing, is independently associated with myocardial injury
after non-cardiac surgery. These data suggest that cardiac
vagal dysfunction is a plausiblemechanism that contributes to
perioperative myocardial injury.Authors’ contributions
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